好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Bartonella Papillitis Mimicking Anti-MOG Optic Neuritis
Infectious Disease
P5 - Poster Session 5 (5:30 PM-6:30 PM)
4-017
To describe an atypical case of Bartonella papillitis.
The anti-myelin oligodendrocyte glycoprotein (MOG) antibody has been associated with a wide variety of neurological presentations. In the field of neuro-ophthalmology, there has been a strong association of anti-MOG with optic neuritis, commonly in combination with optic disc edema, as well as retinopathies such as retinal hemorrhages and serous retinal detachment.
We describe a case of a young lady with a mild preceding viral prodrome who presented with profound subacute monocular vision loss. Examination yielded diminished visual acuity (20/200), a relative afferent pupillary defect, optic disc edema, a small retinal hemorrhage, but no macular starring, or axillary lymphadenopathy. Magnetic Resonance Imaging (MRI) of the brain and optic nerves were unremarkable. Lumbar puncture revealed a bland profile, and the absence of oligoclonal banding. She was treated empirically with antibiotics and corticosteroids.
The patient's visual acuity improved prior to discharge. Immunoglobulins against Bartonella returned positive, and anti-MOG antibody returned negative.
With exciting new developments in the neurology, a continued mind for atypical presentations of traditional diseases is encouraged.
Authors/Disclosures
Peter Sguigna, MD (UT Southwestern Medical Center)
PRESENTER 		Dr. Sguigna has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Sguigna has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Sguigna has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon Therapeutics. The institution of Dr. Sguigna has received research support from Genentech. The institution of Dr. Sguigna has received research support from Clene Nanomedicine. The institution of Dr. Sguigna has received research support from The International Progressive Multiple Sclerosis Alliance through the National Multiple Sclerosis Society. The institution of Dr. Sguigna has received research support from PCORI. The institution of Dr. Sguigna has received research support from DOD/CDMRP. The institution of Dr. Sguigna has received research support from Alexion. Dr. Sguigna has received intellectual property interests from a discovery or technology relating to health care.
Wilmot Bonnet, MD (University of Texas SW Medical School, Child Neurology) Dr. Bonnet has nothing to disclose.
No disclosure on file
Deepa Sirsi, MD (UTSW Medical Center) No disclosure on file
Benjamin M. Greenberg, MD, FAAN (UT Southwestern Medical Center) Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Greenberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Sanofi/Genzyme. Dr. Greenberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech/Roche. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Greenberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Clene. Dr. Greenberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TG Therapeutics. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IQVIA. Dr. Greenberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Greenberg has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Siegel Rare Neuroimmune Association. Dr. Greenberg has or had stock in GenrAb.Dr. Greenberg has or had stock in Clene.Dr. Greenberg has received intellectual property interests from a discovery or technology relating to health care. Dr. Greenberg has received publishing royalties from a publication relating to health care.